Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Natus Medical stock

NTUS
US6390501038
578916

Price

32.96
Today +/-
+0
Today %
+0 %
P

Natus Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Natus Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Natus Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Natus Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Natus Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Natus Medical Stock Price History

DateNatus Medical Price
7/21/202232.96 undefined
7/20/202232.96 undefined

Natus Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Natus Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Natus Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Natus Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Natus Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Natus Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Natus Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Natus Medical’s growth potential.

Natus Medical Revenue, EBIT and net profit per share

DateNatus Medical RevenueNatus Medical EBITNatus Medical Net Income
2025e567.94 M undefined449.38 M undefined74.48 M undefined
2024e541.97 M undefined179.75 M undefined63.59 M undefined
2023e527.54 M undefined73.34 M undefined55.38 M undefined
2022e504.9 M undefined66.91 M undefined50.8 M undefined
2021473.44 M undefined29.38 M undefined13.18 M undefined
2020415.7 M undefined-10 M undefined-16.6 M undefined
2019495.2 M undefined29 M undefined-15.7 M undefined
2018530.9 M undefined12.6 M undefined-22.9 M undefined
2017501 M undefined9.6 M undefined-20.3 M undefined
2016381.9 M undefined56.8 M undefined42.6 M undefined
2015375.9 M undefined55.6 M undefined37.9 M undefined
2014355.8 M undefined50.1 M undefined32.5 M undefined
2013344.1 M undefined39.5 M undefined23.1 M undefined
2012292.3 M undefined14.5 M undefined3.8 M undefined
2011232.9 M undefined13.2 M undefined-11.2 M undefined
2010218.4 M undefined21.3 M undefined11.9 M undefined
2009166.4 M undefined15.5 M undefined11.4 M undefined
2008161.8 M undefined25.2 M undefined17.3 M undefined
2007118.4 M undefined16.2 M undefined9.8 M undefined
200689.9 M undefined12.7 M undefined-900,000 undefined
200543 M undefined5.4 M undefined6.2 M undefined
200436.5 M undefined-200,000 undefined-2.4 M undefined
200331 M undefined-3.2 M undefined-2.7 M undefined
200227 M undefined-8.6 M undefined-7.5 M undefined

Natus Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (M)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
1995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022e2023e2024e2025e
4610151924272731364389118161166218232292344355375381501530495415473504527541567
-50.0066.6750.0026.6726.3212.50-14.8116.1319.44106.9832.5836.443.1131.336.4225.8617.813.205.631.6031.505.79-6.60-16.1613.986.554.562.664.81
50.0050.0060.0066.6768.4262.5059.2651.8558.0658.3362.7962.9263.5662.1160.2459.1756.4755.8258.7260.2860.5361.4256.0957.3658.7953.4957.72----
236101315161418212756751001001291311632022142272342813042912222730000
-100000-4-8-305121625152113143950555691229-10296673179449
-25.00------14.81-29.63-9.68-11.6313.4813.5615.539.049.635.604.7911.3414.0814.6714.701.802.265.86-2.416.1313.1013.8533.0979.19
-100000-3-7-2-2609171111-11323323742-20-22-15-161350556374
-------133.33-71.43--400.00--88.89-35.29--200.00-127.27666.6739.1315.6313.51-147.6210.00-31.826.67-181.25284.6210.0014.5517.46
0.40.40.40.40.60.77.516.116.416.818.719.522.826.628.529.228.629.830.832.633.233.132.633.133.733.633.970000
-------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Natus Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Natus Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (k)LONG-T. REC. (k)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (k)RETAINED EARNINGS (M)OTHER EQUITY (k)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
                                               
1.92.4153.144.937.635.752.215.411.956.933.629.432.823.156.166.682.5247.68956.463.382.175.59
2.83.14.45.25.45.76.68.520.32736.243.854.855.49082.182.399.186.6126.8127115.993.1111.76
000000000000000000000000
1.21.32.23.64.65.34.33.511.719.32523.137.632.840.840.640.148.649.671.579.771.475.767.75
0.20.10.30.70.70.50.614.17.47.587.29.715.12128.911.22218.322.619.220.822.19
6.16.97.962.655.649.147.265.251.565.6125.6108.5129130.7169199.8217.9241.4405.8305.6285.7269.8271.7277.29
1.21.31.31.82.22.72.52.17.914.51414.123.426.126.523.317.91717.322.122.939.736.231.07
0300300300300300000000000000000000
0100100000000000000000000000
0.10.1001.14.89.41037.354.257.770.169.470.296.698.892.886.577.2172.6139.5114.892.765.51
0000000025.85560.992.396.880.49297.296.3107.5113.1173147.6146.4151.3148.66
001.10.30.20.100.11.60.40.47.212.47.47.810.31027.235.636.642.451.948.541.76
1.31.82.82.43.87.911.912.272.6124.1133183.7202184.1222.9229.6217238.2243.2404.3352.4352.8328.7287
7.48.710.76559.45759.177.4124.1189.7258.6292.2331314.8391.9429.4434.9479.6649709.9638.1622.6600.4564.29
                                               
20.824.128.18686.68789.499.6133.1137.8245.5250.4258.9267.5275.4292.1315.3323.7313316.6334.2344.5342.8353.74
60000000000000000000000000
-17.1-18.5-19.7-24.3-31.8-34.5-36.9-30.8-31.7-22.8-5.36.118.97.811.636.468.9106.8149.4129.1102.387.971.384.49
00-1,500-700-200100300100-400700-13,600-13,000-13,700-16,900-18,300-20,300-31,500-39,800-45,000-23,600-38,000-16,300-3,000-13,470
000000000000000000000000
4.35.66.96154.652.652.868.9101115.7226.6243.5264.1258.4268.7308.2352.7390.7417.4422.1398.5416.1411.1424.76
110.80.91.81.71.91.88.29.87.41421.716.432.529.821.423.718.725.228.827.323.436.41
1.51.52.72.72.52.24.35.410.513.411.914.517.617.132.9283642.133.74137.550.542.744.23
0.30.40.30.30.40.50.30.42.14.73.84.54.77.613.312.911.711.327.525.932.229.729.233.74
0000000000000011.3000000000
0.20.2000000018.60.20.20.20.28.510.500003535.450.40.23
33.13.83.94.74.46.57.620.846.523.333.244.241.398.581.269.177.179.992.1133.5142.9145.7114.61
0.20000000018.31.10.90.70.71327.500140154.369.520.36.30.23
00000000.72.36.53.16.9148.58.49.78.13.93.719.416.926.621.211.81
0000000002.64.67.68.1632.84.97.882219.816.71612.9
0.20000000.72.327.48.815.422.815.224.4401311.7151.7195.7106.263.643.524.94
3.23.13.83.94.74.46.58.323.173.932.148.66756.5122.9121.282.188.8231.6287.8239.7206.5189.2139.55
7.58.710.764.959.35759.377.2124.1189.6258.7292.1331.1314.9391.6429.4434.8479.5649709.9638.2622.6600.3564.31
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Natus Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Natus Medical's financial health and stability.

Assets

Natus Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Natus Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Natus Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Natus Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
0000-3-7-2-2609171111-11323323742-20-22-15-1613
000001111346791012121115163033302828
000000000-11101-3-8131-24-13-5-1-4
000-1-2-1-210-8-7-151-17-30-7-9-302-20-141217
00001102011225630106412132649372319
0000000000010000100046431
0000000001250516125101659663
0010-4-6-2273101126112219364236721933603463
0000-1-1-1-10-2-2-5-3-4-5-7-3-5-5-3-4-8-5-8-3
00-10-23-7-615-59-52-34-51-17-19-62-22-10-19-53-160-8-5-12-1
0000-22-5-436-57-49-29-48-13-14-55-18-4-14-49-15600-41
0000000000000000000000000
000000000034-350-10315-38014015-50-501-57
300059002103021021221811-1-15153-90
300-157002103237690113317-2001185-49-48-10-60
0000-100001020000352-5-10-5-1-3-4
0000000000000000000000000
200-129-12-8623-24-345-24-44-9331015131-124-32618-6
0000000000000000000000000
0000000000000000000000000

Natus Medical stock margins

The Natus Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Natus Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Natus Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Natus Medical's sales revenue. A higher gross margin percentage indicates that the Natus Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Natus Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Natus Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Natus Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Natus Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Natus Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Natus Medical Margin History

Natus Medical Gross marginNatus Medical Profit marginNatus Medical EBIT marginNatus Medical Profit margin
2025e57.7 %79.12 %13.11 %
2024e57.7 %33.17 %11.73 %
2023e57.7 %13.9 %10.5 %
2022e57.7 %13.25 %10.06 %
202157.7 %6.21 %2.78 %
202053.62 %-2.41 %-3.99 %
201958.91 %5.86 %-3.17 %
201857.26 %2.37 %-4.31 %
201756.13 %1.92 %-4.05 %
201661.51 %14.87 %11.15 %
201560.52 %14.79 %10.08 %
201460.26 %14.08 %9.13 %
201358.82 %11.48 %6.71 %
201255.87 %4.96 %1.3 %
201156.38 %5.67 %-4.81 %
201059.43 %9.75 %5.45 %
200960.34 %9.31 %6.85 %
200862.11 %15.57 %10.69 %
200763.6 %13.68 %8.28 %
200662.63 %14.13 %-1 %
200562.79 %12.56 %14.42 %
200458.9 %-0.55 %-6.58 %
200358.71 %-10.32 %-8.71 %
200255.19 %-31.85 %-27.78 %

Natus Medical Stock Sales Revenue, EBIT, Earnings per Share

The Natus Medical earnings per share therefore indicates how much revenue Natus Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Natus Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Natus Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Natus Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Natus Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Natus Medical Revenue, EBIT and net profit per share

DateNatus Medical Sales per ShareNatus Medical EBIT per shareNatus Medical Earnings per Share
2025e16.42 undefined0 undefined2.15 undefined
2024e15.67 undefined0 undefined1.84 undefined
2023e15.25 undefined0 undefined1.6 undefined
2022e14.6 undefined0 undefined1.47 undefined
202113.94 undefined0.86 undefined0.39 undefined
202012.37 undefined-0.3 undefined-0.49 undefined
201914.69 undefined0.86 undefined-0.47 undefined
201816.04 undefined0.38 undefined-0.69 undefined
201715.37 undefined0.29 undefined-0.62 undefined
201611.54 undefined1.72 undefined1.29 undefined
201511.32 undefined1.67 undefined1.14 undefined
201410.91 undefined1.54 undefined1 undefined
201311.17 undefined1.28 undefined0.75 undefined
20129.81 undefined0.49 undefined0.13 undefined
20118.14 undefined0.46 undefined-0.39 undefined
20107.48 undefined0.73 undefined0.41 undefined
20095.84 undefined0.54 undefined0.4 undefined
20086.08 undefined0.95 undefined0.65 undefined
20075.19 undefined0.71 undefined0.43 undefined
20064.61 undefined0.65 undefined-0.05 undefined
20052.3 undefined0.29 undefined0.33 undefined
20042.17 undefined-0.01 undefined-0.14 undefined
20031.89 undefined-0.2 undefined-0.16 undefined
20021.68 undefined-0.53 undefined-0.47 undefined

Natus Medical business model

Natus Medical Inc is a US-American medical technology company that operates in two main areas: neurology and neonatal care. The company was founded in 1989 under the name "Neometrics" and has since conducted numerous acquisitions, thus expanding into new areas. The business model of Natus Medical Inc is focused on providing state-of-the-art medical technologies that improve the diagnosis and treatment of patients. The company works closely with medical professionals, hospitals, and clinics to ensure the best possible patient care. The neurology division of Natus Medical Inc focuses on providing diagnostic tools for the diagnosis and monitoring of neurological disorders such as epilepsy, stroke, multiple sclerosis, and the like. Products include electroencephalography (EEG) and electromyography (EMG) devices, neurofeedback systems, and software for reporting. The neonatal care division of Natus Medical Inc offers a wide range of products for the care of premature and newborn infants. These include incubators, ventilators, monitoring devices, and phototherapy systems. Natus Medical Inc products are used in clinics and neonatology departments around the world and aim to improve the health and well-being of newborns. With the acquisition of Otometrics and Bio-logic Systems, Natus Medical Inc has expanded its product range to include audiology products. The audiology division offers a wide range of diagnostic tools for audiologists and ENT physicians, including comprehensive audiometric testing devices for children and adults, balance testing devices, and OAE screening systems. Natus Medical Inc places great emphasis on research and development and continuously invests in new technologies to provide even more effective diagnostic and treatment options for patients. The company is also dedicated to the education and training of healthcare personnel by offering trainings and continuing education for medical staff, as well as comprehensive technical support for the users of its products. Looking to the future, Natus Medical Inc plans further expansion, particularly on an international level. The company already has a strong presence in North America and now aims to expand in Europe and Asia. The company focuses on adapting its products and services to the different needs and requirements of each market. Overall, Natus Medical Inc is an innovative and future-oriented company that provides state-of-the-art medical technologies for the diagnosis and treatment of patients. With continuous investments in research and development, as well as its strong presence in the international market, the company is well positioned to continue growing and maintain its leading position in the medical technology industry. Natus Medical is one of the most popular companies on Eulerpool.com.

Natus Medical SWOT Analysis

Strengths

  • Natus Medical Inc has a strong product portfolio offering a wide range of medical devices and solutions.
  • The company has a reputable brand name and a strong presence in the healthcare industry.
  • Natus Medical Inc has a well-established distribution network, allowing them to reach a large customer base globally.
  • The company has a dedicated and experienced research and development team, enabling them to innovate and introduce new products.

Weaknesses

  • Natus Medical Inc may be vulnerable to regulatory changes and compliance requirements, which could impact their operations and product development.
  • The company relies heavily on third-party suppliers for certain components, creating a risk of supply chain disruptions.
  • Natus Medical Inc faces intense competition from other established medical device manufacturers, which could impact their market share and pricing power.

Opportunities

  • The growing global healthcare market presents opportunities for Natus Medical Inc to expand their product offerings and enter new geographic markets.
  • Increasing demand for non-invasive medical devices and technology creates an opportunity for Natus Medical Inc to develop and market innovative solutions.
  • Strategic partnerships and collaborations with healthcare providers and research institutions can help Natus Medical Inc enhance their product development capabilities and market reach.

Threats

  • Economic downturns and financial uncertainty in the healthcare industry can impact Natus Medical Inc's revenues and customer spending.
  • Rapid technological advancements and evolving customer preferences may require Natus Medical Inc to continuously invest in research and development to stay competitive.
  • Changing regulatory landscape and increased scrutiny on medical device safety and efficacy may lead to additional compliance requirements and higher costs for Natus Medical Inc.

Natus Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Natus Medical historical P/E ratio, EBIT multiple, and P/S ratio

Natus Medical shares outstanding

The number of shares was Natus Medical in 2023 — This indicates how many shares 33.97 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Natus Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Natus Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Natus Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Natus Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Unfortunately, there are currently no price targets and forecasts available for Natus Medical.

Natus Medical shareholders

%
Name
Stocks
Change
Date
8.80354 % The Vanguard Group, Inc.3,044,52080,28512/31/2021
7.07634 % Victory Capital Management Inc.2,447,205137,19712/31/2021
5.26545 % Allspring Global Investments, LLC1,820,946101,89912/31/2021
3.81242 % State Street Global Advisors (US)1,318,446-9,21812/31/2021
3.80736 % Dimensional Fund Advisors, L.P.1,316,69712,65512/31/2021
3.10671 % Janus Henderson Investors1,074,391-68,37212/31/2021
2.13412 % Columbia Threadneedle Investments (UK)738,04151,63912/31/2021
16.39542 % BlackRock Institutional Trust Company, N.A.5,670,013144,63312/31/2021
1.89703 % Impax Asset Management LLC656,049012/31/2021
1.75275 % Geode Capital Management, L.L.C.606,15215,86312/31/2021
1
2
3
4
5
...
10

Natus Medical Executives and Management Board

Mr. Austin Noll54
Natus Medical Executive Vice President, Chief Commercial Officer
Compensation 2.79 M
Mr. B. Drew Davies55
Natus Medical Chief Financial Officer, Executive Vice President
Compensation 1.48 M
Mr. Ilan Daskal55
Natus Medical Independent Director
Compensation 294,277
Ms. Alice Schroeder65
Natus Medical Independent Director
Compensation 248,518
Mr. Thomas Sullivan59
Natus Medical President, Chief Executive Officer, Director (since 2019)
Compensation 245,018
1
2

Most common questions regarding Natus Medical

What values and corporate philosophy does Natus Medical represent?

Natus Medical Inc represents a set of core values and a corporate philosophy that underpins its operations. The company is committed to improving patient outcomes through innovative medical solutions. Natus Medical Inc prioritizes integrity, quality, and excellence in every aspect of its business. By fostering a culture of collaboration, the company encourages teamwork and collective effort towards achieving its mission. Natus Medical Inc also emphasizes the importance of accountability, transparency, and ethical practices, ensuring trust and confidence among its stakeholders. With a focus on delivering superior healthcare products and services, Natus Medical Inc continually strives to make a positive impact in the industry.

In which countries and regions is Natus Medical primarily present?

Natus Medical Inc is primarily present in various countries and regions worldwide. The company has a global presence and operates in several key markets, including North America, Europe, Asia Pacific, and Latin America. Natus Medical Inc's products and services are available in many countries, including the United States, Canada, Germany, France, China, Japan, Australia, and Brazil, among others. With its extensive international reach, Natus Medical Inc aims to cater to a broad customer base and provide its innovative medical solutions across different parts of the world.

What significant milestones has the company Natus Medical achieved?

Natus Medical Inc has achieved several significant milestones in its history. One notable accomplishment is the development and introduction of the revolutionary Nicolet™ systems, which have revolutionized neurodiagnostic testing. Additionally, the company has successfully expanded its global footprint and established a strong presence in emerging markets. Natus Medical Inc has also received various accolades, including being named one of the fastest-growing companies in the United States. Furthermore, the company has made strategic acquisitions to enhance its product portfolio and strengthen its market position. These milestones demonstrate Natus Medical Inc's continuous dedication to innovation, growth, and excellence in the medical technology industry.

What is the history and background of the company Natus Medical?

Natus Medical Inc is a healthcare company specializing in the development and manufacturing of medical devices and software. Established in 1989, Natus Medical has a rich history of over three decades in providing innovative solutions for medical professionals worldwide. With its headquarters in Pleasanton, California, the company has expanded its global footprint, serving customers in over 100 countries. Natus Medical is committed to enhancing patient care and outcomes through its products, which include neurology, newborn care, and diagnostics equipment. As a trusted name in the industry, Natus Medical Inc continues to leverage its expertise to offer cutting-edge solutions that advance the field of healthcare.

Who are the main competitors of Natus Medical in the market?

The main competitors of Natus Medical Inc in the market include companies such as Medtronic PLC, Philips Healthcare, and GE Healthcare. These industry leaders also provide a wide range of medical device and equipment solutions. However, Natus Medical Inc distinguishes itself through its innovative product offerings, strong market presence, and focus on neurology and newborn care. Despite facing competition from established players, Natus Medical Inc continues to thrive and excel in delivering high-quality healthcare solutions to its customers worldwide.

In which industries is Natus Medical primarily active?

Natus Medical Inc is primarily active in the healthcare industry.

What is the business model of Natus Medical?

Natus Medical Inc.'s business model focuses on providing medical devices and services for newborn care, neurology, and hearing screening. The company develops and sells innovative products that help diagnose and monitor medical conditions in babies, children, and adults. Natus Medical Inc. offers a range of solutions, including neurodiagnostic systems, hearing screening devices, and newborn care products. By striving for continuous innovation and adhering to the highest quality standards, Natus Medical Inc. aims to improve patient outcomes and enhance healthcare practices. With a strong commitment to delivering reliable and efficient medical solutions, Natus Medical Inc. continues to be a leading player in the healthcare industry.

What is the P/E ratio of Natus Medical 2024?

The Natus Medical P/E ratio is 17.61.

What is the P/S ratio of Natus Medical 2024?

The Natus Medical P/S ratio is 2.07.

What is the AlleAktien quality score of Natus Medical?

The AlleAktien quality score for Natus Medical is 5/10.

What is the revenue of Natus Medical 2024?

The expected Natus Medical revenue is 541.97 M USD.

How high is the profit of Natus Medical 2024?

The expected Natus Medical profit is 63.59 M USD.

What is the business model of Natus Medical

Natus Medical Inc is a leading company in the development, manufacturing, and marketing of medical devices and accessories in various segments. The company is headquartered in Pleasanton, California and has branches in different countries around the world. The company operates in three business segments: newborn care, neurology, and diagnostics.

What is the Natus Medical dividend?

Natus Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Natus Medical pay dividends?

The dividend cannot currently be calculated for Natus Medical or the company does not pay out a dividend.

What is the Natus Medical ISIN?

The ISIN of Natus Medical is US6390501038.

What is the Natus Medical WKN?

The WKN of Natus Medical is 578916.

What is the Natus Medical ticker?

The ticker of Natus Medical is NTUS.

How much dividend does Natus Medical pay?

Over the past 12 months, Natus Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Natus Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Natus Medical?

The current dividend yield of Natus Medical is .

When does Natus Medical pay dividends?

Natus Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Natus Medical?

Natus Medical paid dividends every year for the past 0 years.

What is the dividend of Natus Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Natus Medical located?

Natus Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Natus Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Natus Medical from 10/1/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/1/2024.

When did Natus Medical pay the last dividend?

The last dividend was paid out on 10/1/2024.

What was the dividend of Natus Medical in the year 2023?

In the year 2023, Natus Medical distributed 0 USD as dividends.

In which currency does Natus Medical pay out the dividend?

The dividends of Natus Medical are distributed in USD.

All fundamentals about Natus Medical

Our stock analysis for Natus Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Natus Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.